1. Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1
   Huan Fang et al, 2023, eLife CrossRef
2. Integrin α6β4 signals through DNA damage response pathway to sensitize breast cancer cells to cisplatin
   Min Chen et al, 2022, Frontiers in Oncology CrossRef
3. Integrin β4 promotes DNA damage-related drug resistance in triple-negative breast cancer via TNFAIP2/IQGAP1/RAC1
   Huan Fang et al, 2023, eLife CrossRef